Mostly hunger/cravings and portion control discuss GLP-1 options (if medically appropriate)
More caution is warranted
14 Another study showed that four months of daily oral glutathione supplementation, combined with lifestyle improvements, produced positive effects on liver health in some individuals with non-alcoholic fatty liver disease (NAFLD)
Tirzepatide, in the SURMOUNT trials, was even more aggressive, with average losses of 16 to 22.5% depending on the dose
Conclusion Both Semaglutide and Tirzepatide are effective for weight loss and diabetes management, each with its own benefits and potential drawbacks
Peptides marketed for weight loss AOD 9604, BPC-157, tesofensine analogs, and similar compounds are discussed in the context of the evidence (or lack of evidence) supporting their use for weight management